Analysis of c-Myc function in normal cells via conditional gene-targeted mutation

Immunity

Volumn 14, Issue 1, 2001, Pages 45-55

  De Alboran, Ignacio Moreno ^a   O'Hagan, Rónán C ^a   Gärtner, Frank ^a   Malynn, Barbara ^a   Davidson, Laurie ^a   Rickert, Robert ^b   Rajewsky, Klaus ^c   DePinho, Ronald A ^a   Alt, Frederick W ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; FAS ANTIGEN; FAS LIGAND; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; FIBROBLAST; GENE DELETION; GENE INACTIVATION; GENE MUTATION; GENE TARGETING; GERM LINE; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL;

EID: 0035129209     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(01)00088-7     Document Type: Article

References (60)

1. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
2. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis
3. Etoposide: Current status and future perspectives in the management of malignant neoplasms
4. Repression of c-Myc responsive genes in cycling cells causes G1 arrest through reduction of cyclin E/CDK2 kinase activity
5. Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27
6. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas
7. Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation
8. Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle
9. Cloning and characterization of different human sequences related to the oncogene (v-myc) of avian myelocytomatosis virus (MC29)
10. A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice
11. Autocrine T-cell suicide mediated by APO-1
12. The MYC protein activates transcription of the alpha-prothymosin gene
13. Induction of apoptosis in fibroblasts by c-myc protein
14. Role of cyclin A and p27 in anti-IgM-induced G1 growth arrest of murine B-cell lymphomas
15. The molecular role of Myc in growth and transformation: Recent discoveries lead to new insights
16. Lymphoma models for B cell activation and tolerance. X. Anti-mu-mediated growth arrest and apoptosis of murine B cell lymphomas is prevented by the stabilization of myc
17. Cdc25 cell-cycle phosphatase as a target of c-myc
18. Transforming growth factor beta1 inhibits fas ligand expression and subsequent activation-induced cell death in T cells via downregulation of c-Myc
19. Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting
20. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1
21. Proteins of the Myc network: Essential regulators of cell growth and differentiation
22. Identification of CDK4 as a target of c-MYC
23. Participation of cyclin A in Myc-induced apoptosis
24. Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis
25. c-Myc enhances protein synthesis and cell size during B cell development
26. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation
27. Anti-IgM-mediated regulation of c-myc and its possible relationship to apoptosis
28. Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor
29. Suppression of Myc, but not E1a, transformation activity by Max-associated proteins, Mad and Mxi1
30. Consequences of widespread deregulation of the c-myc gene in transgenic mice: Multiple neoplasms and normal development
31. Human retinoblastoma susceptibility gene: Cloning, identification, and sequence
32. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F
33. c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II
34. Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination
35. c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points
36. Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins
37. Use of transgenic mice to study myc family gene function in normal mammalian development and in cancer
38. Myc family oncoproteins function through a common pathway to transform normal cells in culture: Cross-interference by Max and trans-acting dominant mutants
39. Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclinE/cdk2 complexes
40. Mysterious liaisons: The relationship between c-Myc and the cell cycle
41. Myc enhanced expression of Cul1 promotes ubiquitin-dependent proteolysis and cell cycle progression
42. Quail embryo fibroblasts transformed by four v-myc-containing virus isolates show enhanced proliferation but are non tumorigenic
43. CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells
44. Expansion or elimination of B cells in vivo: Dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor
45. B lymphocyte-specific, Cre-mediated mutagenesis in mice
46. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor
47. Activation of cyclin-dependent kinases by Myc mediates induction of cyclin A, but not apoptosis
48. Identification of nucleotide sequences which may encode the oncogenic capacity of avian retrovirus MC29
49. Down-modulation of c-myc expression induces apoptosis of B lymphocyte models of tolerance via clonal deletion
50. Complex lymphoid and epithelial thymic tumours in Thy1-myc transgenic mice
51. Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes
52. Differential responsiveness of myc- and ras-transfected cells to growth factors: Selective stimulation of myc-transfected cells by epidermal growth factor
53. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells
54. The many roles of c-Myc in apoptosis
55. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc
56. c-myc protein expression in untransformed fibroblasts
57. Inhibition of c-myc expression induces apoptosis of WEHI 231 murine B cells
58. Increased p27Kip1 cyclin-dependent kinase inhibitor gene expression following anti-IgM treatment promotes apoptosis of WEHI 231 B cells
59. Expression and function of myc family genes
60. Cell cycle: On target with Myc